News & Media
About Abiomed and Impella® Heart Pumps
Based in Danvers, Massachusetts, USA, Abiomed, Inc. (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory and respiratory support. Our cardiac products are designed to enable the heart to rest and recover by improving blood flow and/or performing the pumping of the heart. Our easy-to-use respiratory product is designed to oxygenate the blood, while promoting mobility.
Impella heart pumps are the only U.S. Food and Drug Administration-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI or treatment of AMI cardiogenic shock. Impella has the unique ability to enable your heart to recover, allowing patients to return home from the hospital with their native hearts.
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure
October 21, 2022